Blood Reprogramming Technologies

Blood Reprogramming Technologies (BRT) was founded in March 2017 as a spin-off from the Center for Neuroscience and Cell Biology, University of Coimbra in Portugal. BRT is specialized in R&D and in the use of direct cell reprogramming technologies to generate autologous blood products with clinical application for regenerative medicine and immunotherapy. We are developing blood products focusing on 2 major areas: hematopoietic stem cell (HSC) transplantation and immunotherapy.